Specification

उत्पत्ति
India

संकेत
Used in the treatment of various cancers including lymphoma, leukemia, breast cancer, and ovarian cancer; also used for nephrotic syndrome and autoimmune disorders.

नमक की संरचना
Cyclophosphamide

खुराक प्रपत्र
Injection

फ़ीचर

सामग्रियां

एप्लीकेशन

पीएच लेवल
3.0 - 7.0 (when reconstituted)

भौतिक रंग/बनावट

स्टोरेज निर्देश
Store below 25C. Protect from light and freeze.

शेल्फ लाइफ
वर्ष

Contraindications
Hypersensitivity to cyclophosphamide or excipients; severe bone marrow suppression

Packaging Material
Clear glass vial with rubber stopper and aluminium cap

Adverse Effects
Nausea, vomiting, alopecia, bone marrow suppression, immunosuppression, hemorrhagic cystitis

Pack Type
Single-use vial

Strength(s) Available
200 mg, 500 mg, 1 g vials

Route of Administration
Intravenous (IV) or intramuscular (IM)

Prescription Status
Prescription only medicine

Regulatory Status
Manufactured as per GMP/WHO standards

Precautions
Use with caution in patients with hepatic or renal impairment.

Reconstitution Requirements
Reconstitute with sterile water for injection before use.

Trade Information

Minimum Order Quantity
1 टुकड़ा

आपूर्ति की क्षमता
प्रति दिन

डिलीवरी का समय
हफ़्ता

About

Cyclophosphamide Injection is a redoubtable, highly effective alkylating agent, widely in demand for the management of lymphoma, leukemia, breast and ovarian cancers, nephrotic syndrome, and autoimmune disorders. This noteworthy product is available in strengths of 200 mg, 500 mg, and 1g, supplied in clear glass single-use vials. Carefully reconstitute with sterile water before administration via IV or IM route. Please reserve only on prescription, and redeem top-quality safety as it is manufactured under GMP/WHO guidelines. Valiant handling is required due to potential side effects and necessary precautions in certain patient populations.

Therapeutic Significance and Usage Areas

Cyclophosphamide Injection is primarily utilized in oncological settings for the treatment of various cancers such as lymphoma, leukemia, breast, and ovarian cancer. Additionally, its application extends to managing nephrotic syndrome and several autoimmune disorders. Approved for both intravenous and intramuscular use, this injection supports tailored therapeutic approaches in hospitals and specialized clinics where advanced chemotherapy regimens and immunosuppressive treatments are required.

Export Details and Quality Certifications

Our cyclophosphamide injection is available for export from India, with the primary FOB port being Mumbai. Upon receiving a valid Purchase Order and finalized Offer, delivery can be arranged within the committed timeframe, typically within 2-4 weeks. Each export meets stringent GMP/WHO certification standards to ensure global compliance and top-grade quality. Sale price is competitive and negotiable for large orders through authorized suppliers, traders, and wholesalers.

FAQ's of cyclophosphamide injection:

Q: How should cyclophosphamide injection be prepared and administered?

A: Cyclophosphamide injection must be reconstituted with sterile water for injection according to the instructions provided on the vial. It should then be administered either intravenously or intramuscularly by a qualified healthcare professional.

Q: What are the primary indications for using cyclophosphamide injection?

A: Cyclophosphamide injection is indicated for the treatment of several cancers, including lymphoma, leukemia, breast cancer, and ovarian cancer. It is also used for nephrotic syndrome and certain autoimmune disorders.

Q: When should cyclophosphamide injection be avoided?

A: This medication is contraindicated in patients with known hypersensitivity to cyclophosphamide or its excipients and in those with severe bone marrow suppression. Consultation with a medical professional is essential before use.

Q: What precautions should be taken when using cyclophosphamide injection?

A: Cyclophosphamide should be used with caution in patients with hepatic or renal impairment. Close monitoring for adverse effects such as bone marrow suppression and hemorrhagic cystitis is advised throughout treatment.

Q: What are the possible side effects associated with cyclophosphamide injection?

A: Common side effects include nausea, vomiting, alopecia, bone marrow suppression, immunosuppression, and hemorrhagic cystitis. Patients should inform their doctor of any unusual symptoms during treatment.

Q: Where can I obtain cyclophosphamide injection for hospital or clinic use?

A: Cyclophosphamide injection can be reserved through licensed exporters, suppliers, traders, and wholesalers in India. It is available as a single-use vial upon prescription only.